Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer

Ovarian cancer is the deadliest of all gynecologic cancers. Despite success with initial chemotherapy, the majority of patients relapse with an incurable disease. Development of chemotherapy resistance is a major factor for poor long-term survival in ovarian cancer. The biological effects of estroge...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinyou, Viswanadhapalli, Suryavathi, Garcia, Lauren, Zhou, Mei, Nair, Binoj C., Kost, Edward, Tekmal, Rajeshwar Rao, Li, Rong, Rao, Manjeet K., Curiel, Tyler, Vadlamudi, Ratna K., Sareddy, Gangadhara R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564823/
https://www.ncbi.nlm.nih.gov/pubmed/28654894
http://dx.doi.org/10.18632/oncotarget.18442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564823/
https://www.ncbi.nlm.nih.gov/pubmed/28654894
http://dx.doi.org/10.18632/oncotarget.18442

Ejemplares similares